Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.
Most adults feel statins do not offer enough benefit to start the treatment and willingness to start rises with increasing heart disease risk, a new survey of US and Japanese participants finds.